Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (30 ops.)
Latest filing published 05 Jan 2026 for Arrowhead Pharmaceuticals, INC., €416k. Read the official filing
Filing timeline
BuySaleChristopher Richard Anzalone
Insider track record
Disclosed buys
0
Disclosed sells
30
Signal history
Christopher Richard Anzalone: trading record in brief
Christopher Richard Anzalone (chief executive) discloses dealings in Arrowhead Pharmaceuticals, Inc. to SEC (Form 4). Over a trading history stretching from 30 December 2015 to 2 January 2026, the count stands at 50 filings.
Every open-market trade on record is a sale: 30 sales worth €22.4M. Besides market trades, the filings include 8 share grants and 11 option exercises. 2026 to date brings no purchases and 1 sale.
On 5 January 2026 came the latest disclosure, an open-market sale for €416k in Arrowhead Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Christopher Richard Anzalone
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations50 total
7,416 shares@ US$65.880.021% mcap1.5% of flowCommon StockSEC:0001423029-26-000001:0
16,545 shares@ US$68.693.5% of flowCommon StockSEC:0001423029-25-000009:3
16,545 shares@ US$6.150.3% of flowCommon StockSEC:0001423029-25-000009:1
35,181 shares@ US$69.337.6% of flowCommon StockSEC:0001423029-25-000009:2
35,181 shares@ US$6.150.0091% mcap0.7% of flowCommon StockSEC:0001423029-25-000009:0
3,979 shares@ US$66.670.011% mcap0.8% of flowCommon StockSEC:0001423029-25-000007:0
10,012 shares@ US$68.332.1% of flowCommon StockSEC:0001423029-25-000007:3
2,574 shares@ US$68.850.6% of flowCommon StockSEC:0001423029-25-000007:4
8,147 shares@ US$68.011.7% of flowCommon StockSEC:0001423029-25-000007:1
1,319 shares@ US$68.480.3% of flowCommon StockSEC:0001423029-25-000007:2
46,287 shares@ US$63.550.12% mcap9.2% of flowCommon StockSEC:0001423029-25-000005:0
180,000 shares0Common StockSEC:0001423029-25-000003:0
100,532 shares@ US$68.6721.6% of flowCommon StockSEC:0001423029-25-000003:1
8,147 shares@ US$69.961.8% of flowCommon StockSEC:0001423029-25-000003:3
8,416 shares@ US$60.511.6% of flowCommon StockSEC:0001423029-25-000003:4
14,095 shares@ US$62.122.7% of flowCommon StockSEC:0001423029-25-000003:6
8,476 shares@ US$62.941.7% of flowCommon StockSEC:0001423029-25-000003:7
6,661 shares@ US$64.291.3% of flowCommon StockSEC:0001423029-25-000003:8
1,000 shares@ US$64.960.2% of flowCommon StockSEC:0001423029-25-000003:9
1,300 shares@ US$65.770.3% of flowCommon StockSEC:0001423029-25-000003:10
166 shares@ US$66.770.0% of flowCommon StockSEC:0001423029-25-000003:11
3,221 shares@ US$67.870.7% of flowCommon StockSEC:0001423029-25-000003:12
21,321 shares@ US$69.284.6% of flowCommon StockSEC:0001423029-25-000003:2
10,963 shares@ US$61.252.1% of flowCommon StockSEC:0001423029-25-000003:5
35,305 shares@ US$9.931.2% of flowCommon StockSEC:0001628280-25-017592:0
25 of 50 declarations
